Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: JOEBT1 who wrote (178)	4/10/1998 10:21:00 PM
From: John O'Neill	Respond to of 3044

joebt1.....I'm a MLNM fan and trade the stock. Regarding MCDE, the $6.1 mil figure is the total outlay over 3 years, not per year. Alex Brown (1/15/98 & 2/11/98). estimate payments to Iconix of $1.1mil in 1998 and $2.1 mil in each of 99 & 2000. The funding will partially cover antiviral drug discovery research at Iconix.......MCDE will retain rights to any antivirals discovered during the collaboration. I read it as a positive entry into antiviral work. David Stone/Steve Scala analyst see MCDE with 8 years of cash coverage and no need to raise cash before their first product are launched (prob 4-5 years). HEY I don't want to hog the MLNM thread. The "microcide breakout" thread shows with the SI chart..any posting there are appreciated. JO